• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

ASP4132

CAS No. 1640294-30-9

ASP4132 ( —— )

产品货号. M22042 CAS No. 1640294-30-9

ASP4132 是一种口服活性 AMPK 激活剂 (EC50 : 18 nM),具有抗癌活性。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥713 有现货
5MG ¥1077 有现货
10MG ¥1677 有现货
25MG ¥3046 有现货
50MG ¥4560 有现货
100MG ¥6423 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    ASP4132
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    ASP4132 是一种口服活性 AMPK 激活剂 (EC50 : 18 nM),具有抗癌活性。
  • 产品描述
    ASP4132 is an orally active AMPK activator (EC50 : 18 nM), has anti-cancer activity.(In Vitro):ASP4132 shows comparable cell growth inhibitory (IC50=0.014 μM) activity against MDA-MB-453 breast cancer cell.ASP4132 shows relatively weak antiproliferative activity against SK-BR-3 (IC50>3 μM).(In Vivo):ASP4132 (0.5-8 mg/kg; PO; once daily; for 21 days) causes the tumor growth inhibition and regression.ASP4132 (1 mg/kg; IV or PO) has a T1/2 of 3.6 hours, a CLtot of 19 mL/min?kg, and a Vss of 4.6 L/kg for rats for IV.ASP4132 is stable in human liver microsomes (HLM CLint, vitro=61 mL/min?kg).
  • 体外实验
    ASP4132 shows comparable cell growth inhibitory (IC50=0.014 μM) activity against MDA-MB-453 breast cancer cell. ASP4132 shows relatively weak antiproliferative activity against SK-BR-3 (IC50>3 μM).
  • 体内实验
    ASP4132 (0.5-8 mg/kg; PO; once daily; for 21 days) causes the tumor growth inhibition and regression. ASP4132 (1 mg/kg; IV or PO) has a T1/2 of 3.6 hours, a CLtot of 19 mL/min?kg, and a Vss of 4.6 L/kg for rats for IV. ASP4132 is stable in human liver microsomes (HLM CLint, vitro=61 mL/min?kg). Animal Model:Five-week-old male nude mice with MDA-MB-453 Dosage:0.5, 1, 2, 4, 8 mg/kg Administration:PO; once daily; for 21 days Result:The tumor growth inhibition (TGI) rate was 29% at 1 mg/kg, and the tumor regression rate was 26%, 87% and 96% at 2, 4 and 8 mg/kg, respectively. Animal Model:Male SD rats Dosage:1 mg/kg (Pharmacokinetic Analysis) Administration:IV or PO Result:Had a T1/2 of 3.6 hours, a CLtot of 19 mL/min?kg, and a Vss of 4.6 L/kg for rats for IV. Had a Cmax of 72 ng/mL and an AUC24h of 705 ng?h/mL for PO.
  • 同义词
    ——
  • 通路
    Membrane Transporter/Ion Channel
  • 靶点
    AMPK
  • 受体
    AMPK
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    1640294-30-9
  • 分子量
    937.06
  • 分子式
    C46H51F3N6O8S2
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO:230 mg/mL (245.45 mM; Need ultrasonic); Methanol:8.33 mg/mL (8.89 mM; Need ultrasonic)
  • SMILES
    CC1=CC=C(C=C1)S(O)(=O)=O.CC1=CC=C(C=C1)S(O)(=O)=O.COC1=CC=C(CN2CCC(CC2)C2=CC=C3N=C(NC3=C2)C(=O)N2CCN(CC3=CC=C(C=C3)C(F)(F)F)CC2)C=N1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Kazuyuki Kuramoto , Yuki Sawada, Tomohiro Yamada,et al.Novel Indirect AMP-Activated Protein Kinase Activators: Identification of a Second-Generation Clinical Candidate with Improved Physicochemical Properties and Reduced hERG Inhibitory Activity.Chem Pharm Bull (Tokyo). 2020;68(5):452-465.
产品手册
关联产品
  • Dorsomorphin

    Dorsomorphin(BML-275,化合物 C)是一种有效的、选择性的、可逆的 AMPK 抑制剂,Ki 为 109 nM。

  • MT 63-78

    MT 63-78 是一种特异有效的直接 AMPK 激活剂 (EC50: 25 μM)。 MT 63-78 通过抑制脂肪生成和 mTORC1 途径来阻止前列腺癌的生长。

  • YLF-466D

    YLF-466D 是一种新型 AMPK 激活剂,可抑制血小板聚集。